SITC Cancer Immunotherapy CONNECT

SITC Biotech Strategic Meeting at the NYSE

Friday, June 27, 2025, from 9 A.M.–2 P.M. ET

This exclusive event will bring together experts, investors, and biotech innovators to discuss the future of T-cell engagers, China’s impact on IO clinical research, and strategic pathways for novel immunotherapy advancements.

Learn more, view the schedule and faculty & register >

A New Interview Series from SITC

From Conception to Launch to Funding: Spinning Technology from Academia to Biotech

In this insightful interview, leading experts, Dr. Bruce Levine (Founding Director, Clinical Cell and Vaccine Production Facility at the Perelman School of Medicine at the University of Pennsylvania) and Dr. Samir Khleif (founder and CEO of Georgiamune) discuss the evolving landscape of academic innovation and tech transfer in oncology, immunotherapy, and biotech commercialization.

Watch the interview >

Learn from clinical experts with the 2025 Advances in Cancer Immunotherapy (ACI) Series

ACI programs are certified for CME credits and are free for healthcare professionals, students, patients and patient advocates.

Join A Focus on Gastrointestinal Cancers April 23. New focus points for this year include a discussion of recent developments and ongoing studies of adoptive cellular therapies for gastrointestinal cancers.

Learn More >

Improve your training with the SITC-NCI Computational Immuno-oncology Webinar Series

This year's series will focus specifically on advanced methods and clinical utility for biomarker development in IO.

Stay abreast of the latest technologies - register today for the entire series of ten FREE webinars from SITC.

Register for Free >

Learn from key leaders in the field at the Targets for Cancer IO: A Deep Dive Live Webinar Series

This series will include six live webinars addressing various hot topics in immuno-oncology.

An interactive Q&A session will follow the topic overview, providing the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field.

Register Now >